Skip to content
value.today

Clairity, Inc.

🇺🇸 Austin, Texas, USAHealth CareFounded 2019

Formerly Boston Health AI, Inc.

Total raised
$10 M
2 rounds on record
Latest round
$7 M
Sep 2022
First round on record
Jan 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Clairity, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2022$7 MNo. 2$2 to $10 million

Clairity, Inc.: Raise no. 2, Sep 2022

Investors in this round

3 investors had bought by the notice of Oct 17, 2022: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $30 M offered; $23 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brandon Weaver · Executive Officer
  • Caroline Ivers Reeuwijk · Executive Officer, Director
  • Phillippe Raffy · Executive Officer
  • Gabriella Antici · Director · Elected in connection with the initial closing of the financing.
  • Joe Cunningham · Director
  • Kevin Lalande · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “A portion of the Total Remaining to be Sold is reserved for issuance and sale at additional closing(s) to be held after the date hereof, and the remainder will be issued and sold upon the Company achieving certain contingencies at a milestone closing.”

Signed by Caroline Ivers Reeuwijk, President & CEO. Source: SEC Form D, newest notice filed Oct 17, 2022. Read the notice at the SEC.

equitySEC
Jan 2021$4 MNo. 1$2 to $10 million

Clairity, Inc.: Raise no. 1, Jan 2021

Investors in this round

3 investors had bought by the notice of Feb 10, 2021: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $9 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kevin Lalande · Executive Officer, Director
  • Joe Cunningham · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Lalande, President. Source: SEC Form D, newest notice filed Feb 10, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Clairity, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2022).

    SEC Form D · Oct 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2022

That is all the official record says: Clairity, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Clairity, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 3 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Clairity, Inc.
NameRoleNamed in
Brandon WeaverExecutive officerOct 2022
Caroline Ivers ReeuwijkExecutive officerOct 2022
Phillippe RaffyExecutive officerOct 2022
Kevin LalandeExecutive officerFeb 2021
Caroline Ivers ReeuwijkDirectorOct 2022
Gabriella AnticiElected in connection with the initial closing of the financing.Oct 2022
Joe CunninghamDirectorOct 2022
Kevin LalandeDirectorOct 2022